Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
37.08
-0.20 (-0.54%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.66 billion as of April 28, 2026. Its market cap has increased by 91.19% in one year.
Market Cap
2.66B
Enterprise Value
2.10B
1-Year Change
91.19%
Ranking
Category
Stock Price
$37.08
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.66B, an increase of 1,080.42%. That is a compound annual growth rate of 64.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.67B | -25.63% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 2.78B |
| Kodiak Sciences | 2.77B |
| Soleno Therapeutics | 2.73B |
| Beam Therapeutics | 2.72B |
| IDEAYA Biosciences | 2.70B |
| Immunome | 2.67B |
| Enliven Therapeutics | 2.65B |
| Disc Medicine | 2.63B |